CHEST Physician
-
Novel obesity medications open door to new era in treatment of OSA
In December 2024, the FDA approved tirzepatide, a dual GIP and GLP-1 receptor agonist previously approved for type 2 diabetes and obesity, as the first prescription medication for adults with moderate to severe OSA and obesity.
-
COVID-19 immune patterns offer hope for future IPF treatment
Jose D. Herazo-Maya, MD, and colleagues are investigating a mechanism of T-cell suppression that may contribute to the development of a treatment for pulmonary fibrosis.
-
Understanding high-risk factors like PM2.5 in lung cancer
Renelle Myers, MD, FRCPC, discusses factors beyond tobacco use that clinicians should consider when screening for lung cancer, such as pollution exposure.
-
Putting women’s health front and center in lung cancer screening
CHEST President, John Howington, MD, MBA, FCCP, focuses on women’s health and the need to spread awareness about lung cancer screening among women.
-
Breathing room: Making space for palliative care in lung transplant programs
Transplant centers should consider additional research into palliative care integration to ultimately benefit the growing population of lung transplant recipients.
-
Becoming a leader as a woman in chest medicine
The Women in Chest Medicine Interest Group spoke with Past President, Doreen Addrizzo-Harris, MD, FCCP, and President-Designate, Lisa K. Moores, MD, FCCP, to learn valuable insights about how to get involved.
-
Top reads from the CHEST journal portfolio – March 2025
Read commentary on studies about the effectiveness of guideline-recommended activities for children with asthma, predictors of medical mistrust in the ICU, and developing an algorithm to apply NIV in acute exacerbation of COPD.
-
CHEST 2025 is not one to miss
The CHEST 2025 Scientific Program Committee gathered at CHEST Headquarters to solidify the curriculum for the upcoming meeting. With more than 300 sessions planned, there will be something for every clinician.
-
Striking the right balance: Optimizing mechanical ventilation settings for diaphragm protection
Personalizing mechanical ventilation using noninvasive techniques, like ventilator graphics to monitor patient respiratory effort, offers a practical and effective strategy to prevent diaphragm dysfunction and optimize patient outcomes.
-
Study demonstrates viability of biologics for severe asthma, COPD exacerbations in eosinophilic inflammation
While larger studies are needed, Dharani K. Narendra, MD, FCCP, said the findings from the ABRA trial could be a game changer and reduce the need for glucocorticoids for some patients.
